Get the Stockscreener App
30.99
1.49%
-0.47
Atricure Inc stock is traded at $30.99, with a volume of 538.72K.
It is down -1.49% in the last 24 hours and down -15.79% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$31.46
Open:
$31.45
24h Volume:
538.72K
Relative Volume:
0.88
Market Cap:
$1.54B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-40.25
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
-0.64%
1M Performance:
-15.79%
6M Performance:
-13.10%
1Y Performance:
-18.79%
1-Day Range:
$30.86
$32.55
1-Week Range:
$29.58
$32.55
52-Week Range:
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
30.99 | 1.57B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-11-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
Aug Weekly: Why is AtriCure Inc stock going down2025 Sector Review & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AtriCure (ATRC) CEO receives stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CMO granted stock awards, uses shares to cover taxes - Stock Titan
AtriCure (ATRC) CTO awarded 45,588 shares, withholds 13,127 for tax - Stock Titan
AtriCure (ATRC) CSO granted stock, transfers shares to cover taxes - Stock Titan
AtriCure (ATRC) CFO granted 63,088 shares and transfers stock for taxes - Stock Titan
AtriCure (ATRC) COO receives stock awards and surrenders shares for taxes - Stock Titan
AtriCure (ATRC) CLO receives stock awards and surrenders shares for taxes - Stock Titan
A Look At AtriCure (ATRC) Valuation After Strong 2025 Earnings And Upbeat 2026 Outlook - simplywall.st
Vanguard Group Inc. Sells 65,324 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 59.63% Upside as Analysts Stay Bullish - DirectorsTalk Interviews
AtriCure (NASDAQ:ATRC) Releases FY 2026 Earnings Guidance - MarketBeat
Champlain Investment Partners LLC Sells 38,541 Shares of AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure’s (ATRC) 2026 Profitability Guidance Mark a Turning Point in Its Investment Narrative? - Yahoo Finance
3 Small-Cap ‘Strong Buy’ Stocks with Big Upside in 2026, According to Analysts - TipRanks
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 37.3% in February - MarketBeat
Oversold Conditions For AtriCure (ATRC) - Nasdaq
AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 55.32% Potential Upside and Analysts’ Strong Buy Ratings - DirectorsTalk Interviews
AtriCure to Participate in the Citizens Life Sciences Conference - BioSpace
Aug Opening: Is XWELL Inc exposed to currency risksSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Price-Driven Insight from (ATRC) for Rule-Based Strategy - Stock Traders Daily
Nasdaq Moves: Is QDEL likely to announce a buybackInflation Watch & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Will AtriCure Inc. stock go up in YEARJuly 2025 Spike Watch & Safe Capital Preservation Plans - mfd.ru
AtriCure (NASDAQ:ATRC) Upgraded at Wall Street Zen - MarketBeat
Hood River Capital Management LLC's Strategic Acquisition of Atr - GuruFocus
ETFs Investing in AtriCure, Inc. Stocks - TradingView
AtriCure (NASDAQ:ATRC) Cut to Hold at Zacks Research - MarketBeat
Is AtriCure (NASDAQ:ATRC) Facing New Pressure In The Nasdaq Index? - Kalkine Media
Decoding AtriCure Inc (ATRC): A Strategic SWOT Insight - GuruFocus
AtriCure, Inc. SEC 10-K Report - TradingView
COR's MWI Animal Health to Merge With Covetrus in $3.5 Billion Deal - Finviz
AtriCure Earnings Call Highlights Growth Amid Headwinds - TipRanks
Demystifying AtriCure: Insights From 6 Analyst Reviews - Benzinga
ATRC: Canaccord Genuity Lowers Price Target, Maintains Buy Ratin - GuruFocus
Needham reiterates Buy on AtriCure stock, keeps $45 target - Investing.com UK
Needham reiterates Buy on AtriCure stock, keeps $45 target By Investing.com - Investing.com Nigeria
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026? - Finviz
UBS Adjusts AtriCure Price Target to $55 From $60, Maintains Buy Rating - marketscreener.com
UBS Maintains 'Buy' Rating on AtriCure (ATRC), Lowers Price Targ - GuruFocus
Citizens Jmp Cuts AtriCure (NASDAQ:ATRC) Price Target to $52.00 - MarketBeat
AtriCure (ATRC) Analyst Maintains Rating, Lowers Price Target to $52 | ATRC Stock News - GuruFocus
AtriCure Delivers 15% Revenue Growth In FY25, Projects 12-14% Growth In FY26 - Nasdaq
This Masimo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
AtriCure, Inc. (NASDAQ:ATRC) Q4 2025 Earnings Call Transcript - Insider Monkey
AtriCure, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Why AtriCure (ATRC) Is Down 12.9% After Issuing 2026 Profitability Guidance And Revenue Outlook - simplywall.st
BTIG Research Reaffirms "Buy" Rating for AtriCure (NASDAQ:ATRC) - MarketBeat
Oppenheimer downgrades AtriCure stock rating on competitive concerns - Investing.com UK
Oppenheimer downgrades AtriCure stock rating on competitive concerns By Investing.com - Investing.com India
Canaccord Genuity lowers AtriCure stock price target on valuation - Investing.com UK
Canaccord Genuity lowers AtriCure stock price target on valuation By Investing.com - Investing.com India
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):